6.
Fowler J
. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989; 62(740):679-94.
DOI: 10.1259/0007-1285-62-740-679.
View
7.
Zimmerman M, Huang Q, Li F, Liu X, Li C
. Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy. Semin Radiat Oncol. 2013; 23(4):288-95.
PMC: 3891050.
DOI: 10.1016/j.semradonc.2013.05.003.
View
8.
Wozniak A, Moon J, Thomas Jr C, Kelly K, Mack P, Gaspar L
. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer. 2015; 16(5):340-7.
PMC: 4497941.
DOI: 10.1016/j.cllc.2014.12.014.
View
9.
Salameh T, Mortell W, Logsdon A, Butterfield D, Banks W
. Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate. Fluids Barriers CNS. 2019; 16(1):1.
PMC: 6323732.
DOI: 10.1186/s12987-018-0121-6.
View
9.
Rockwell S, Dobrucki I, Kim E, Marrison S, Vu V
. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med. 2009; 9(4):442-58.
PMC: 2752413.
DOI: 10.2174/156652409788167087.
View
10.
Zupanc G, Zupanc F, Sipahi R
. Stochastic cellular automata model of tumorous neurosphere growth: Roles of developmental maturity and cell death. J Theor Biol. 2019; 467:100-110.
DOI: 10.1016/j.jtbi.2019.01.028.
View
11.
Gong L, Zhang Y, Liu C, Zhang M, Han S
. Application of Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine. 2021; 16:1083-1102.
PMC: 7886779.
DOI: 10.2147/IJN.S290438.
View
12.
Ford C, Petrova S, Pound J, Voss J, Melville L, Paterson M
. Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr Biol. 2015; 25(5):577-88.
PMC: 4353688.
DOI: 10.1016/j.cub.2014.12.059.
View
13.
Bernard S, Herzel H
. Why do cells cycle with a 24 hour period?. Genome Inform. 2007; 17(1):72-9.
View
14.
Boemo M, Byrne H
. Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by tumour-associated macrophages. J Theor Biol. 2018; 461:102-116.
PMC: 6269600.
DOI: 10.1016/j.jtbi.2018.10.044.
View
15.
Schlereth K, Weichenhan D, Bauer T, Heumann T, Giannakouri E, Lipka D
. The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. Elife. 2018; 7.
PMC: 5947988.
DOI: 10.7554/eLife.34423.
View
16.
Golden E, Formenti S, Schiff P
. Taxanes as radiosensitizers. Anticancer Drugs. 2013; 25(5):502-11.
DOI: 10.1097/CAD.0000000000000055.
View
17.
Hainsworth J, Spigel D, Greco F, Shipley D, Peyton J, Rubin M
. Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium. Cancer J. 2011; 17(5):267-72.
DOI: 10.1097/PPO.0b013e3182329791.
View
18.
Milas L, Milas M, Mason K
. Combination of taxanes with radiation: preclinical studies. Semin Radiat Oncol. 1999; 9(2 Suppl 1):12-26.
View
19.
Oronsky B, Knox S, Scicinski J
. Six degrees of separation: the oxygen effect in the development of radiosensitizers. Transl Oncol. 2011; 4(4):189-98.
PMC: 3140005.
DOI: 10.1593/tlo.11166.
View